Vitamin D deficiency as a potentially modifiable risk factor for thyroid cancer

Journal of Otolaryngology - Head and Neck Surgery

Volumn 41, Issue 3, 2012, Pages 160-163

  Roskies, Michael ^a   Dolev, Yalon ^b   Caglar, Derin ^c   Hier, Michael P ^b   Mlynarek, Alex ^b   Majdan, Agnieszka ^c   Payne, Richard J ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Risk factor; Thyroid malignancy; Vitamin D deficiency

Indexed keywords

CALCIFEDIOL; VITAMIN D;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID CANCER; THYROID NODULE; THYROIDECTOMY; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; FEMALE; HUMANS; INCIDENCE; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; THYROIDECTOMY; VITAMIN D DEFICIENCY;

EID: 84864241299     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2011.110174     Document Type: Article

References (12)

1. Welsh JE. Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr 2004;80:1721S-4S.
2. Ahonen MH, Tankanen L, Teppo L, et al. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000;11:847-52, doi:10.1023/A:1008923802001.
3. Tangrea J, Helzlsouer K, Pietinen P, et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 1997;8:615-25, doi:10.1023/A:1018450531136. (Pubitemid 27330494)
4. Abbas S, Linseisen T, Slanger T, et al. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer - results of a large case-control study. Carcinogenesis 2008;29:93-9, doi:10.1093/carcin/bgm240. (Pubitemid 351201746)
5. Freedman DM, Looker AC, Abnet CC, et al. Serum vitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res 2010;70:8587-97, doi:10.1158/0008-5472.CAN-10-1420.
6. John EM, Schwartz GG, Koo J, et al. Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol 2007;166:1409-19, doi:10.1093/aje/kwm259. (Pubitemid 350209052)
7. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008;29:726, doi:10.1210/er.2008-0004.
8. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009;115:3801-7, doi:10.1002/cncr.24416.
9. Morris LG, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg 2010;200:454-61, doi:10.1016/j.amjsurg.2009.11.008.
10. Hanley DA, Davison KS. Vitamin D insufficiency in North America. J Nutr 2005;135:332-7. (Pubitemid 40194502)
11. Liu W, Asa SL, Fantus G, et al. Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/Akt-dependent and -independent pathways. Am J Pathol 2002;160:511-9, doi:10.1016/S0002-9440(10)64870-5. (Pubitemid 34160328)
12. Laney N, Meza J, Lyden E, et al. The prevalence of vitamin D deficiency is similar between thyroid nodule and thyroid cancer patients. Int J Endocrinol 2009;2010:3-6.